Abstract
Background
Inflammatory biomarkers are used to guide severe asthma therapy and may also identify activation of underlying inflammatory pathways. We examined biomarker profiles [immunoglobin E (IgE), blood eosinophils, and fractional exhaled nitric oxide (FeNO)] in a severe asthma cohort by employing both conventional cut-off values and cluster analysis.
Inflammatory biomarkers are used to guide severe asthma therapy and may also identify activation of underlying inflammatory pathways. We examined biomarker profiles [immunoglobin E (IgE), blood eosinophils, and fractional exhaled nitric oxide (FeNO)] in a severe asthma cohort by employing both conventional cut-off values and cluster analysis.
Original language | English |
---|---|
Publication status | Accepted/In press - 19 Mar 2020 |
Event | Respiratory Effectiveness Group Summit 2020 - Duration: 19 Mar 2020 → 21 Mar 2020 |
Conference
Conference | Respiratory Effectiveness Group Summit 2020 |
---|---|
Period | 19/03/20 → 21/03/20 |